Financing children's vaccines

Vaccine

Volumn 27, Issue SUPPL. 5, 2009, Pages

  Nelson, E Anthony S ^a   Sack, David ^b   Wolfson, Lara ^c   Walker, Damian G ^d   Seng, Lim Fong ^e   Steele, Duncan ^c,f  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e NATIONAL HEALTHCARE GROUP POLYCLINICS   (Singapore)

^f PATH   (United States)

Author keywords

Economic analysis; Financing; GAVI Alliance; GIVS; Vaccines

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA POLIOMYELITIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; VACCINE;

ARTICLE; CHILD; COMMUNICABLE DISEASE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DECISION MAKING; DEVELOPING COUNTRY; DIARRHEA; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FUNDING; HEALTH CARE POLICY; HUMAN; IMMUNIZATION; INCOME; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; TUBERCULOSIS; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 71949126865     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.072     Document Type: Article

References (17)

1. Centers for Disease Control and Prevention (CDC). Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006-2015. MMWR Wkly 55 18 (2006) 511-515
2. McKinsey. Accelerated introduction of priority new vaccines in developing countries. 2002. http://www.gavialliance.org/resources/McKinsey_pres.pdf.
3. Glass R.I., Parashar U.D., Bresee J.S., Turcios R., Fischer T.K., Widdowson M.A., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 368 9532 (2006) 323-332
4. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New Engl J Med 354 1 (2006) 23-33
5. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New Engl J Med 354 1 (2006) 11-22
6. Bloom D.E., Canning D., and Weston M. The value of vaccination. World Economics 6 3 (2005) 15-39
7. Sack D.A. When should cholera vaccine be used in cholera-endemic areas?. J Health Popul Nutr 21 4 (2003) 299-303
8. World Health Organization. Generic protocol for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children. Field test version. WHO Publication, WHO/V&B/02.15; 2002.
9. World Health Organization. Guidelines for estimating the economic burden of dirrhoeal disease with focus on assessing the impact of rotavirus diarrhoea. Geneva: WHO Publication, WHO/IVB/05.10; 2005.
10. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B.J., and Stoddart G.L. Methods for economic evaluation of health care programmes (2005), Oxford University Press, Oxford
11. Fischer T.K., Anh D.D., Antil L., Cat N.D., Kilgore P.E., Thiem V.D., et al. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 192 10 (2005) 1720-1726
12. Walker D.G., and Rheingans R. Cost-effectiveness of rotavirus vaccines. Expert Rev Pharmacoeco Outcomes Res 5 5 (2005) 593-601
13. Podewils L.J., Antil L., Hummelman E., Bresee J., Parashar U.D., and Rheingans R. Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 192 Suppl 1 (2005) S133-S145
14. World Health Organization. Investing in health research and development: report of the Ad Hoc committee on health research relating to future intervention options. Geneva: World Health Organization; 1996.
15. World Health Organization. World health statistics 2009. (2009), World Health Organization, Geneva p. 116
16. Kaddar M., Lydon P., and Levine R. Financial challenges of immunization: a look at GAVI. Bull World Health Organ 82 9 (2004) 697-702
17. Wolfson L.J., Gasse F., Lee-Martin S.P., Lydon P., Magan A., Tibouti A., et al. Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. Bull World Health Organ 86 1 (2008) 27-39